ECSP055865A - Perindopril - Google Patents

Perindopril

Info

Publication number
ECSP055865A
ECSP055865A EC2005005865A ECSP055865A ECSP055865A EC SP055865 A ECSP055865 A EC SP055865A EC 2005005865 A EC2005005865 A EC 2005005865A EC SP055865 A ECSP055865 A EC SP055865A EC SP055865 A ECSP055865 A EC SP055865A
Authority
EC
Ecuador
Prior art keywords
perindoprile
reciprocal
integers
integer
formula
Prior art date
Application number
EC2005005865A
Other languages
English (en)
Inventor
Rajendra Narayanrao Kankan
Charmaraj Ramachandra Rao
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ECSP055865A publication Critical patent/ECSP055865A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Una sal farmacéuticamente aceptable de perindopril de fórmula (I) preparada a partir de un compuesto precursor protegido de fórmula (II) en donde R representa un grupo protector carboxilo, cuyo proceso comprende someter un compuesto de fórmula (II) a desprotección del grupo carboxílico COOR adherido al anillo heterocíclico de tal forma que produzca el correspondiente ácido libre, cuya desprotección se lleva a cabo en la presencia de una base que forma una sal farmacéuticamente aceptable con dicho ácido libre formado mediante dicha desprotección
EC2005005865A 2002-11-18 2005-06-17 Perindopril ECSP055865A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0226885A GB2395195A (en) 2002-11-18 2002-11-18 Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors

Publications (1)

Publication Number Publication Date
ECSP055865A true ECSP055865A (es) 2005-11-22

Family

ID=9948057

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005865A ECSP055865A (es) 2002-11-18 2005-06-17 Perindopril

Country Status (28)

Country Link
US (1) US7351840B2 (es)
EP (2) EP1565485B1 (es)
JP (2) JP5110770B2 (es)
KR (1) KR20050075429A (es)
CN (2) CN1966519A (es)
AT (2) ATE352555T1 (es)
AU (2) AU2003283588B2 (es)
BR (1) BR0315703A (es)
CA (1) CA2506587A1 (es)
DE (2) DE60329722D1 (es)
DK (1) DK1565485T3 (es)
EC (1) ECSP055865A (es)
ES (2) ES2279188T3 (es)
GB (1) GB2395195A (es)
GE (1) GEP20105036B (es)
HR (1) HRPK20050567B3 (es)
IL (1) IL168660A (es)
IS (1) IS7893A (es)
MA (1) MA27567A1 (es)
MX (1) MXPA05005333A (es)
NZ (1) NZ540360A (es)
PL (1) PL376931A1 (es)
PT (2) PT1565485E (es)
RU (1) RU2339645C2 (es)
SI (1) SI1565485T1 (es)
TN (1) TNSN05140A1 (es)
WO (1) WO2004046172A1 (es)
ZA (1) ZA200503979B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
PL1636185T3 (pl) 2003-06-24 2012-12-31 Servier Lab Nowe formy krystaliczne peryndoprylu erbuminy
GB2413128A (en) * 2004-04-13 2005-10-19 Neopharma Ltd Process for the preparation of perindopril
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
WO2007017893A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited Preparation of novel crystalline form of perindopril erbumine monohydrate
CA2615691C (en) * 2005-07-25 2015-11-10 Lek Pharmaceuticals D.D. Process for the preparation of crystalline perindopril
EA014773B1 (ru) * 2005-08-12 2011-02-28 Лек Фармасьютиклз Д.Д. Способ получения эрбумина периндоприла
EP1942886A1 (en) * 2005-08-12 2008-07-16 Sandoz AG New crystalline form of perindopril erbumine
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CN101332191B (zh) * 2008-07-10 2013-01-09 沈阳药科大学 一种稳定的培哚普利叔丁胺盐片剂及其制备方法
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
US8558023B2 (en) 2010-04-20 2013-10-15 Chiral Quest, Inc. Enantioselective process for cycloalkenyl β-substituted alanines
CN103110929A (zh) * 2012-12-10 2013-05-22 江苏开元医药化工有限公司 米屈肼和赖诺普利的药物组合物及其制备方法
CN105693817B (zh) * 2014-11-27 2020-06-05 西北大学 一类三肽化合物及其制备方法与应用
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
JP4018854B2 (ja) * 1999-10-28 2007-12-05 第一三共株式会社 抗悪性腫瘍薬
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
SI21881A (sl) * 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine

Also Published As

Publication number Publication date
ES2279188T3 (es) 2007-08-16
KR20050075429A (ko) 2005-07-20
EP1688427A1 (en) 2006-08-09
ZA200503979B (en) 2006-11-29
GB0226885D0 (en) 2002-12-24
CN100371345C (zh) 2008-02-27
SI1565485T1 (sl) 2007-08-31
US20060063941A1 (en) 2006-03-23
IL168660A (en) 2010-04-15
ATE352555T1 (de) 2007-02-15
CA2506587A1 (en) 2004-06-03
MA27567A1 (fr) 2005-10-03
PL376931A1 (pl) 2006-01-09
JP2006520320A (ja) 2006-09-07
DE60311516D1 (en) 2007-03-15
US7351840B2 (en) 2008-04-01
MXPA05005333A (es) 2005-08-16
PT1565485E (pt) 2007-03-30
NZ540360A (en) 2007-12-21
ES2333153T3 (es) 2010-02-17
GEP20105036B (en) 2010-07-12
AU2009202389A1 (en) 2009-07-09
AU2003283588A1 (en) 2004-06-15
TNSN05140A1 (en) 2007-05-14
EP1688427B1 (en) 2009-10-14
PT1688427E (pt) 2009-11-06
BR0315703A (pt) 2005-10-25
RU2005119162A (ru) 2006-01-20
JP2013006839A (ja) 2013-01-10
DE60311516T2 (de) 2007-10-25
DE60329722D1 (de) 2009-11-26
HRP20050567A2 (hr) 2005-12-31
CN1966519A (zh) 2007-05-23
AU2009202389B2 (en) 2012-03-29
GB2395195A (en) 2004-05-19
HRPK20050567B3 (en) 2007-08-31
WO2004046172A1 (en) 2004-06-03
DK1565485T3 (da) 2007-03-12
ATE445632T1 (de) 2009-10-15
IS7893A (is) 2005-06-14
EP1565485A1 (en) 2005-08-24
CN1738830A (zh) 2006-02-22
AU2003283588B2 (en) 2009-07-16
JP5110770B2 (ja) 2012-12-26
EP1565485B1 (en) 2007-01-24
RU2339645C2 (ru) 2008-11-27

Similar Documents

Publication Publication Date Title
MA27567A1 (fr) Perindopril
DK1485359T3 (da) Natriumkanalblokkere
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
AR051778A2 (es) Derivados del acido dimetilaminocrotonico y procesos para supreparacion
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
BR0109836A (pt) Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
DK1310502T3 (da) Phosphonocephem-forbindelse
DK1385515T3 (da) Spiropyrazole forbindelser
EP1420010A4 (en) AMPHOTERE LIPID COMPOUND AND USE THEREOF
ATE272617T1 (de) Sulfonamid-derivate
ATE431328T1 (de) Photopolymerisierbare verbindungen
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE312829T1 (de) Als matrix-metalloproteinasehemmer verwendbare tricyclische sulfonamide
NO20050834L (no) Ny indolinforbindelse og medisinsk anvendelse derav
UY26778A1 (es) Derivados de ácido heteroarilalcanoico.